Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | FHL2 |
Upstream (Parents) |
---|
(<<) S100A6 → FHL2 |
(<<) PKM2 → FHL2 |
(<<) S100A11 → FHL2 |
(<<) LGALS3 → FHL2 |
Downstream (Children) |
---|
FHL2 → PTOV1 (>>) |
FHL2 → INPP4B (>>) |
FHL2 → QSOX1 (>>) |
FHL2 → S100A2 (>>) |
FHL2 → TFF1 (>>) |
FHL2 → MUC1 (>>) |
FHL2 → EPHA4 (>>) |
FHL2 → AHNAK2 (>>) |
FHL2 → FGF3 (>>) |
FHL2 → TP63 (>>) |
FHL2 → ZZEF1 (>>) |
FHL2 → PFKP (>>) |
FHL2 → BACE2 (>>) |
FHL2 → HBEGF (>>) |
FHL2 → S100A11 (>>) |
FHL2 → PTGES (>>) |
FHL2 → HCG9 (>>) |